Cargando…

Molecular immune pathogenesis and diagnosis of COVID-19

Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaowei, Geng, Manman, Peng, Yizhao, Meng, Liesu, Lu, Shemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104082/
https://www.ncbi.nlm.nih.gov/pubmed/32282863
http://dx.doi.org/10.1016/j.jpha.2020.03.001
_version_ 1783512171413504000
author Li, Xiaowei
Geng, Manman
Peng, Yizhao
Meng, Liesu
Lu, Shemin
author_facet Li, Xiaowei
Geng, Manman
Peng, Yizhao
Meng, Liesu
Lu, Shemin
author_sort Li, Xiaowei
collection PubMed
description Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-7104082
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Xi'an Jiaotong University
record_format MEDLINE/PubMed
spelling pubmed-71040822020-03-31 Molecular immune pathogenesis and diagnosis of COVID-19 Li, Xiaowei Geng, Manman Peng, Yizhao Meng, Liesu Lu, Shemin J Pharm Anal Review Paper Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection. Xi'an Jiaotong University 2020-04 2020-03-05 /pmc/articles/PMC7104082/ /pubmed/32282863 http://dx.doi.org/10.1016/j.jpha.2020.03.001 Text en © 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Paper
Li, Xiaowei
Geng, Manman
Peng, Yizhao
Meng, Liesu
Lu, Shemin
Molecular immune pathogenesis and diagnosis of COVID-19
title Molecular immune pathogenesis and diagnosis of COVID-19
title_full Molecular immune pathogenesis and diagnosis of COVID-19
title_fullStr Molecular immune pathogenesis and diagnosis of COVID-19
title_full_unstemmed Molecular immune pathogenesis and diagnosis of COVID-19
title_short Molecular immune pathogenesis and diagnosis of COVID-19
title_sort molecular immune pathogenesis and diagnosis of covid-19
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104082/
https://www.ncbi.nlm.nih.gov/pubmed/32282863
http://dx.doi.org/10.1016/j.jpha.2020.03.001
work_keys_str_mv AT lixiaowei molecularimmunepathogenesisanddiagnosisofcovid19
AT gengmanman molecularimmunepathogenesisanddiagnosisofcovid19
AT pengyizhao molecularimmunepathogenesisanddiagnosisofcovid19
AT mengliesu molecularimmunepathogenesisanddiagnosisofcovid19
AT lushemin molecularimmunepathogenesisanddiagnosisofcovid19